MAPT and Alzheimer disease: Besides, some scholars have found that the elevated brain insulin is crucial in treating the AD-like changes in T2D, and Ex-4 reduces the AD-like tau hyperphosphorylation in T2D by promoting the brain insulin and insulin signalling (Reger et al. 2006; Yang et al. 2013).